1,669
Views
6
CrossRef citations to date
0
Altmetric
Laboratory Study

Protective potential of Angelica sinensis polysaccharide extract against ethylene glycol-induced calcium oxalate urolithiasis

, , &
Pages 618-627 | Received 28 May 2018, Accepted 28 Jun 2018, Published online: 06 Nov 2018

References

  • Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327:1141–1152.
  • Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006;367:333–344.
  • Ackaert KS, Schroder FH. Effects of extracorporeal shock wave lithotripsy (ESWL) on renal tissue. A review. Urol Res. 1989;17:3–7.
  • Rule AD, Lieske JC, Li X, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014;25:2878–2886.
  • Lin WC, Lai MT, Chen HY. Protective effect of Flos carthami extract against ethylene glycol-induced urolithiasis in rats. Urol Res. 2012;40:655–661.
  • Das M, Malipeddi H. Antiurolithiatic activity of ethanol leaf extract of Ipomoea eriocarpa against ethylene glycol-induced urolithiasis in male Wistar rats. Indian J Pharmacol. 2016;48:270–274.
  • Araujo Viel T, Diogo Domingos C, da Silva Monteiro AP, et al. Evaluation of the antiurolithiatic activity of the extract of Costus spiralis Roscoe in rats. J Ethnopharmacol. 1999;66:193–198.
  • Sayana SB, Khanwelkar CC, Nimmagadda VR, et al. Evaluation of antiurolithic activity of alcoholic extract of roots of cissampelos pareira in albino rats. Int J Basic Clin Pharmacol. 2014;3:1–04.
  • Grases F, Ramis M, Costa-Bauza A, et al. Effect of Herniaria hirsuta and Agropyron repens on calcium oxalate urolithiasis risk in rats. J Ethnopharmacol. 1995;45:211–214.
  • Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005;78:431–441.
  • Wang KP, Zeng F, Liu JY, et al. Inhibitory effect of polysaccharides isolated from Angelica sinensis on hepcidin expression. J Ethnopharmacol. 2011;134:944–948.
  • Jin M, Zhao K, Huang Q, et al. Isolation, structure and bioactivities of the polysaccharides from Angelica sinensis (Oliv.) Diels: a review. Carbohydr Polym. 2012;89:713–722.
  • Zhang S, He B, Ge J. Extraction, chemical analysis of Angelica sinensis polysaccharides and antioxidant activity of the polysaccharides in ischemia-reperfusion rats. Int J Biol Macromol. 2010;47:546–550.
  • Wang K, Cao P, Shui W, et al. Angelica sinensis polysaccharide regulates glucose and lipid metabolism disorder in prediabetic and streptozotocin-induced diabetic mice through the elevation of glycogen levels and reduction of inflammatory factors. Food Funct. 2015;6:902–909.
  • Zhang Y, Cheng Y, Wang N, et al. The action of JAK, SMAD and ERK signal pathways on hepcidin suppression by polysaccharides from Angelica sinensis in rats with iron deficiency anemia. Food Funct. 2014;5:1381–1388.
  • Khan A, Bashir S, Khan SR, et al. Antiurolithic activity of Origanum vulgare is mediated through multiple pathways. BMC Complement Altern Med. 2011;11:96.
  • Aslan Z, Aksoy L. Anti-inflammatory effects of royal jelly on ethylene glycol induced renal inflammation in rats. Int Braz J Urol. 2015;41:1008–1013.
  • Zhang X, Aggarwal P, Li X, et al. The role of lithium carbonate and lithium citrate in regulating urinary citrate level and preventing nephrolithiasis. Int J Biomed Sci. 2009;5:215–222.
  • Kulaksızoğlu S, Sofikerim M, Çevik C. In vitro effect of lemon and orange juices on calcium oxalate crystallization. Int Urol Nephrol. 2008;40:589–594.
  • Atmani F, Slimani Y, Mimouni M, et al. Effect of aqueous extract from Herniaria hirsuta L. on experimentally nephrolithiasic rats. J Ethnopharmacol. 2004;95:87–93.
  • Khan SR, Glenton PA. Deposition of calcium phosphate and calcium oxalate crystals in the kidneys. J Urol. 1995;153:811–817.
  • Khan SR. Animal models of kidney stone formation: an analysis. World J Urol. 1997;15:236–243.
  • Khan A, Byer K, Khan SR. Exposure of Madin-Darby canine kidney (MDCK) cells to oxalate and calcium oxalate crystals activates nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase. Urology. 2014;83:510.e1–517.
  • Umekawa T, Iguchi M, Uemura H, et al. Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int. 2006;98:656–660.
  • Hess B, Zipperle L, Jaeger P. Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation. Am J Physiol. 1993;265:F784–F791.
  • Fuselier HA, Ward DM, Lindberg JS, et al. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers. Urology. 1995;45:942–946.
  • Pak CY. Medical stone management: 35 years of advances. J Urol. 2008;180:813–819.
  • Bayir Y, Halici Z, Keles MS, et al. Helichrysum plicatum DC. subsp. plicatum extract as a preventive agent in experimentally induced urolithiasis model. J Ethnopharmacol. 2011;138:408–414., no.
  • Chen YH, Liu HP, Chen HY, et al. Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis. Kidney Int. 2011;80:369–377.
  • Orhan N, Onaran M, Şen İ, et al. Preventive treatment of calcium oxalate crystal deposition with immortal flowers. J Ethnopharmacol. 2015;163:60–67.
  • Miller J, Chi T, Kapahi P, et al. Drosophila melanogaster as an emerging translational model of human nephrolithiasis. J Urol. 2013;190:1648–1656.
  • Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol. 2014;3:256–276.
  • Khan SR, Glenton PA, Backov R, et al. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int. 2002;62:2062–2072.
  • Thamilselvan S, Khan SR, Menon M. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res. 2003;31:3–9.
  • Khan SR. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol. 2013;189:803–811.
  • Pietta PG. Flavonoids as antioxidants. J Nat Prod. 2000;63:1035–1042.
  • Runchel C, Matsuzawa A, Ichijo H. Mitogen-activated protein kinases in mammalian oxidative stress responses. Antioxid Redox Signal. 2011;15:205–218.
  • Yin T, Sandhu G, Wolfgang CD, et al. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem. 1997;272:19943–19950.
  • Park J, Kim I, Oh YJ, et al. Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2. J Biol Chem. 1997;272:16725–16728.
  • Prozialeck WC, Edwards JR, Lamar PC, et al. Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Toxicol Appl Pharmacol. 2009;238:306–314.
  • Waanders F, Vaidya VS, van Goor H, et al. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Am J Kidney Dis. 2009;53:16–25.
  • Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;73:863–869.
  • Kanaguchi Y, Suzuki Y, Osaki K, et al. Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Nephrol Dial Transplant. 2011;26:3465–3473.